Begin Your Journey by clicking the link : This article should be used as an educational resource to help you explore lifestyle habits, selfmanagement techniques, and wellness
Tirzepatide (Mounjaro) , a dual GIP/GLP-1 receptor agonist, has been under NICE appraisal for weight management
SaiyanMed is not responsible for outcomes, interpretations, or conclusions drawn from any studies conducted using these products
Patients who struggle with injections or have injection anxiety may achieve better long-term outcomes with oral formulations, despite needing higher doses and stricter administration protocols
For this reason, some people actually gain weight during their semaglutide treatment
Conclusions In individuals with T2DM, semaglutide and tirzepatide demonstrate comparable weight-loss efficacy at specific dose combinations, with equivalence driven by dose rather than drug identity